# Neomorph

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neomorph

- Industry: Biotechnology
- Headquarters: San Diego, US
- Website: www.neomorph.com/
- Total disclosed funding: $100M
- Latest round: Series B (Apr 13, 2026)
- Investors on record: 5

## About

Neomorph, Inc. is engaged in the development of therapeutic solutions by utilizing its proprietary technology platform. Neomorph, Inc. was co-founded in 2020 by Phil Chamberlain, Eric Fischer, Benjamin Ebert and Scott Armstrong. The firm is headquartered in San Diego, US. In April 2026, Neomorph, Inc. raised USD 100 million in series B funding led by returning investor Deerfield Management, with participation from other new investors Regeneron Ventures, Longwood Fund, Alexandria Venture Investments, and Binney Street Capital. Other unspecified investors also participated in the round. Neomorph, Inc. specializes in discovering and developing targeted protein degradation drugs aimed at eliminating disease-causing proteins. Their offerings include molecular glue degraders which repurpose cellular mechanisms to achieve targeted protein degradation, primarily serving pharmaceutical firms in oncology and other therapeutic areas across North America and Europe. The revenue model for Neomorph is centered around collaborations and licensing agreements with global healthcare entities, including upfront fees and milestone payments associated with R&D progress. This transactional structure enables a steady revenue influx while allowing larger partners to spearhead clinical development initiatives. The company will use the April 2026 funding to advance its lead program NEO-811 through a Phase 1/2 clinical trial and to expand a broader pipeline of molecular glue degrader therapies across multiple disease areas.

## Funding rounds

- Series B, Apr 13, 2026, $100M — Alexandria Venture Investments, Longwood Fund, Deerfield Management, Binney Street Capital, Regeneron Ventures
- Seed, Mar 31, 2020 — Deerfield Management

## Investors

- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Seed, Series B
- Alexandria Venture Investments (https://capitalatlas.ai/funds/alexandria-venture-investments) — Series B
- Longwood Fund (https://capitalatlas.ai/funds/longwood-fund) — Series B
- Binney Street Capital (https://capitalatlas.ai/funds/binney-street-capital) — Series B
- Regeneron Ventures (https://capitalatlas.ai/funds/regeneron-ventures) — Series B